{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:44:03Z","timestamp":1776822243196,"version":"3.51.2"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T00:00:00Z","timestamp":1749427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s00204-025-04099-9","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T06:20:37Z","timestamp":1749450037000},"page":"3803-3824","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An evaluation of the human relevance of the hepatocellular tumors observed in mice treated with synthetic fungicide, pyridachlometyl, based on mode of action"],"prefix":"10.1007","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3775-2912","authenticated-orcid":false,"given":"Kensuke","family":"Kawamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukako","family":"Shimotsuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5047-0962","authenticated-orcid":false,"given":"Samuel M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-1049","authenticated-orcid":false,"given":"Tomoya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,9]]},"reference":[{"issue":"1","key":"4099_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/10408444.2013.835785","volume":"44","author":"ME Andersen","year":"2014","unstructured":"Andersen ME, Preston RJ, Maier A, Willis AM, Patterson J (2014) Dose\u2013response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: results of a workshop. Crit Rev Toxicol 44(1):50\u201363. https:\/\/doi.org\/10.3109\/10408444.2013.835785","journal-title":"Crit Rev Toxicol"},{"issue":"10","key":"4099_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/10408440600977677","volume":"36","author":"AR Boobis","year":"2006","unstructured":"Boobis AR, Cohen SM, Dellarco V et al (2006) IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36(10):781\u2013792. https:\/\/doi.org\/10.1080\/10408440600977677","journal-title":"Crit Rev Toxicol"},{"issue":"2","key":"4099_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/toxsci\/kfl100","volume":"94","author":"DR Boverhof","year":"2006","unstructured":"Boverhof DR, Burgoon LD, Tashiro C et al (2006) Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL\/6 mice. Toxicol Sci 94(2):398\u2013416. https:\/\/doi.org\/10.1093\/toxsci\/kfl100","journal-title":"Toxicol Sci"},{"key":"4099_CR4","volume-title":"The usefulness of in vitro mechanistic information in regulatory dossiers\u2014the case of the CAR mode of action in carcinogenicity assessment","author":"T Capel\u00f4a","year":"2024","unstructured":"Capel\u00f4a T, Prieto P, Berggren E, Corvi R (2024) The usefulness of in vitro mechanistic information in regulatory dossiers\u2014the case of the CAR mode of action in carcinogenicity assessment. Publications Office of the European Union, Luxembourg"},{"issue":"1","key":"4099_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1006\/toxs.1998.2473","volume":"44","author":"P Carthew","year":"1998","unstructured":"Carthew P, Edwards RE, Nolan BM (1998) The quantitative distinction of hyperplasia from hypertrophy in hepatomegaly induced in the rat liver by phenobarbital. Toxicol Sci 44(1):46\u201351. https:\/\/doi.org\/10.1006\/toxs.1998.2473","journal-title":"Toxicol Sci"},{"issue":"3","key":"4099_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1177\/0192623310363813","volume":"38","author":"SM Cohen","year":"2010","unstructured":"Cohen SM (2010) Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary. Toxicol Pathol 38(3):487\u2013501. https:\/\/doi.org\/10.1177\/0192623310363813","journal-title":"Toxicol Pathol"},{"key":"4099_CR7","doi-asserted-by":"publisher","first-page":"1394584","DOI":"10.3389\/fonc.2024.1394584","volume":"14","author":"SM Cohen","year":"2024","unstructured":"Cohen SM (2024a) Cell proliferation and carcinogenesis: an approach to screening for potential human carcinogens. Front Oncol 14:1394584. https:\/\/doi.org\/10.3389\/fonc.2024.1394584","journal-title":"Front Oncol"},{"key":"4099_CR8","first-page":"226","volume-title":"Comprehensive toxicology","author":"SM Cohen","year":"2024","unstructured":"Cohen SM (2024b) The role of cell proliferation in the etiology of neoplasia. In: McQueen C (ed) Comprehensive toxicology, 3rd edn. Elsevier, Amsterdam, pp 226\u2013247","edition":"3"},{"issue":"1","key":"4099_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1293\/tox.21.1","volume":"21","author":"SM Cohen","year":"2008","unstructured":"Cohen SM, Arnold LL (2008) Cell proliferation and carcinogenesis. J Toxicol Pathol 21(1):1\u20137. https:\/\/doi.org\/10.1293\/tox.21.1","journal-title":"J Toxicol Pathol"},{"issue":"4","key":"4099_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1293\/tox.2016-0036","volume":"29","author":"SM Cohen","year":"2016","unstructured":"Cohen SM, Arnold LL (2016) Critical role of toxicologic pathology in a short-term screen for carcinogenicity. J Toxicol Pathol 29(4):215\u2013227. https:\/\/doi.org\/10.1293\/tox.2016-0036","journal-title":"J Toxicol Pathol"},{"issue":"4972","key":"4099_CR11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1126\/science.2204108","volume":"249","author":"SM Cohen","year":"1990","unstructured":"Cohen SM, Ellwein LB (1990) Cell proliferation in carcinogenesis. Science 249(4972):1007\u20131011. https:\/\/doi.org\/10.1126\/science.2204108","journal-title":"Science"},{"issue":"2","key":"4099_CR12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/toxsci\/kfh073","volume":"78","author":"SM Cohen","year":"2004","unstructured":"Cohen SM, Klaunig J, Meek ME et al (2004) Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci 78(2):181\u2013186. https:\/\/doi.org\/10.1093\/toxsci\/kfh073","journal-title":"Toxicol Sci"},{"issue":"1","key":"4099_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10408444.2013.835784","volume":"44","author":"JC Corton","year":"2014","unstructured":"Corton JC, Cunningham ML, Hummer BT et al (2014) Mode of action framework analysis for receptor-mediated toxicity: the peroxisome proliferator-activated receptor alpha (PPAR\u03b1) as a case study. Crit Rev Toxicol 44(1):1\u201349. https:\/\/doi.org\/10.3109\/10408444.2013.835784","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"4099_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00204-017-2094-7","volume":"92","author":"JC Corton","year":"2018","unstructured":"Corton JC, Peters JM, Klaunig JE (2018) The PPAR\u03b1-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. Arch Toxicol 92(1):83\u2013119. https:\/\/doi.org\/10.1007\/s00204-017-2094-7","journal-title":"Arch Toxicol"},{"issue":"6","key":"4099_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/j.cell.2007.07.019","volume":"130","author":"J Dong","year":"2007","unstructured":"Dong J, Feldmann G, Huang J et al (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130(6):1120\u20131133. https:\/\/doi.org\/10.1016\/j.cell.2007.07.019","journal-title":"Cell"},{"issue":"1","key":"4099_CR16","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3109\/10408444.2013.835786","volume":"44","author":"CR Elcombe","year":"2014","unstructured":"Elcombe CR, Peffer RC, Wolf DC et al (2014) Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. Crit Rev Toxicol 44(1):64\u201382. https:\/\/doi.org\/10.3109\/10408444.2013.835786","journal-title":"Crit Rev Toxicol"},{"issue":"2","key":"4099_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1539-6924.1988.tb01174.x","volume":"8","author":"LB Ellwein","year":"1988","unstructured":"Ellwein LB, Cohen SM (1988) A cellular dynamics model of experimental bladder cancer: analysis of the effect of sodium saccharin in the rat. Risk Anal 8(2):215\u2013221. https:\/\/doi.org\/10.1111\/j.1539-6924.1988.tb01174.x","journal-title":"Risk Anal"},{"issue":"2","key":"4099_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3109\/00498254.2013.867553","volume":"44","author":"JR Foster","year":"2014","unstructured":"Foster JR, Lund G, Sapelnikova S, Tyrrell DL, Kneteman NM (2014) Chimeric rodents with humanized liver: bridging the preclinical\/clinical trial gap in ADME\/toxicity studies. Xenobiotica 44(2):109\u2013122. https:\/\/doi.org\/10.3109\/00498254.2013.867553","journal-title":"Xenobiotica"},{"issue":"1","key":"4099_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.14252\/foodsafetyfscj.D-23-00002","volume":"11","author":"FSCJ","year":"2023","unstructured":"FSCJ (2023) Pyridachlometyl (pesticides). Food Saf 11(1):21\u201324. https:\/\/doi.org\/10.14252\/foodsafetyfscj.D-23-00002","journal-title":"Food Saf"},{"key":"4099_CR20","unstructured":"FSCJ (2022) Risk assessment report. Pyridachlometyl [Japanese]. http:\/\/www.fsc.go.jp\/fsciis\/attachedFile\/download?retrievalId=kya20220323038&fileId=210. Accessed 1 May"},{"issue":"2","key":"4099_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/toxsci\/kfu014","volume":"138","author":"DR Geter","year":"2014","unstructured":"Geter DR, Bhat VS, Gollapudi BB, Sura R, Hester SD (2014) Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway. Toxicol Sci off J Soc Toxicol 138(2):425\u2013445. https:\/\/doi.org\/10.1093\/toxsci\/kfu014","journal-title":"Toxicol Sci off J Soc Toxicol"},{"key":"4099_CR22","first-page":"433","volume-title":"Endoplasmic reticulum ultrastructural pathology of the cell and matrix","author":"FN Ghadially","year":"1997","unstructured":"Ghadially FN (1997) Endoplasmic reticulum ultrastructural pathology of the cell and matrix, 4th edn. Btterworth-Heimemann, Boston, MA, pp 433\u2013602","edition":"4"},{"issue":"4","key":"4099_CR23","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/carcin\/5.4.437","volume":"5","author":"RE Greenfield","year":"1984","unstructured":"Greenfield RE, Ellwein LB, Cohen SM (1984) A general probabilistic model of carcinogenesis: analysis of experimental urinary bladder cancer. Carcinogenesis 5(4):437\u2013445. https:\/\/doi.org\/10.1093\/carcin\/5.4.437","journal-title":"Carcinogenesis"},{"issue":"2","key":"4099_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/00498254.2018.1437300","volume":"49","author":"C Haines","year":"2019","unstructured":"Haines C, Chatham LR, Vardy A, Elcombe CR, Foster JR, Lake BG (2019) Comparison of the hepatic and thyroid gland effects of sodium phenobarbital and pregnenolone-16\u03b1-carbonitrile in wild type and constitutive androstane receptor (CAR)\/pregnane X receptor (PXR) knockout rats. Xenobiotica 49(2):227\u2013238. https:\/\/doi.org\/10.1080\/00498254.2018.1437300","journal-title":"Xenobiotica"},{"issue":"7","key":"4099_CR25","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/0192623312448935","volume":"40","author":"AP Hall","year":"2012","unstructured":"Hall AP, Elcombe CR, Foster JR et al (2012) Liver Hypertrophy: a review of adaptive (adverse and non-adverse) changes\u2013onclusions from the 3rd international ESTP expert workshop. Toxicol Pathol 40(7):971\u2013994. https:\/\/doi.org\/10.1177\/0192623312448935","journal-title":"Toxicol Pathol"},{"issue":"1","key":"4099_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.tox.2009.01.007","volume":"258","author":"Y Hirose","year":"2009","unstructured":"Hirose Y, Nagahori H, Yamada T et al (2009) Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes. Toxicology 258(1):64\u201369. https:\/\/doi.org\/10.1016\/j.tox.2009.01.007","journal-title":"Toxicology"},{"issue":"6","key":"4099_CR27","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.fct.2009.03.014","volume":"47","author":"HB Jones","year":"2009","unstructured":"Jones HB, Orton TC, Lake BG (2009) Effect of chronic phenobarbitone administration on liver tumour formation in the C57BL\/10J mouse. Food Chem Toxicol 47(6):1333\u20131340. https:\/\/doi.org\/10.1016\/j.fct.2009.03.014","journal-title":"Food Chem Toxicol"},{"issue":"9","key":"4099_CR28","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/10408444.2024.2377208","volume":"54","author":"JE Klaunig","year":"2024","unstructured":"Klaunig JE, Cohen SM (2024) Mode of action of dieldrin-induced liver tumors: application to human risk assessment. Crit Rev Toxicol 54(9):634\u2013658. https:\/\/doi.org\/10.1080\/10408444.2024.2377208","journal-title":"Crit Rev Toxicol"},{"issue":"2","key":"4099_CR29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/toxsci\/kfz012","volume":"168","author":"M Kondo","year":"2019","unstructured":"Kondo M, Miyata K, Nagahori H et al (2019) Involvement of peroxisome proliferator-activated receptor-\u03b1 in liver tumor production by permethrin in the female mouse. Toxicol Sci 168(2):572\u2013696. https:\/\/doi.org\/10.1093\/toxsci\/kfz012","journal-title":"Toxicol Sci"},{"issue":"1","key":"4099_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/toxsci\/kfaa017","volume":"175","author":"M Kondo","year":"2020","unstructured":"Kondo M, Kikumoto H, Osimitz TG, Cohen SM, Lake BG, Yamada T (2020) An evaluation of the human relevance of the liver tumors observed in female mice treated with permethrin based on mode of action. Toxicol Sci 175(1):50\u201363. https:\/\/doi.org\/10.1093\/toxsci\/kfaa017","journal-title":"Toxicol Sci"},{"issue":"8","key":"4099_CR31","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1080\/00498250903098184","volume":"39","author":"BG Lake","year":"2009","unstructured":"Lake BG (2009) Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation. Xenobiotica 39(8):582\u2013596. https:\/\/doi.org\/10.1080\/00498250903098184","journal-title":"Xenobiotica"},{"issue":"4","key":"4099_CR32","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1039\/c8tx00008ec8tx00008e","volume":"7","author":"BG Lake","year":"2018","unstructured":"Lake BG (2018) Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators. Toxicol Res (Camb) 7(4):697\u2013717. https:\/\/doi.org\/10.1039\/c8tx00008ec8tx00008e","journal-title":"Toxicol Res (Camb)"},{"key":"4099_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.tox.2020.152465","volume":"439","author":"BG Lake","year":"2020","unstructured":"Lake BG, Price RJ, Scott MP, Chatham LR, Vardy A, Osimitz TG (2020) Piperonyl butoxide: mode of action analysis for mouse liver tumour formation and human relevance. Toxicology 439:152465. https:\/\/doi.org\/10.1016\/j.tox.2020.152465","journal-title":"Toxicology"},{"issue":"3","key":"4099_CR34","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1194\/jlr.M800226-JLR200","volume":"50","author":"JM Maglich","year":"2009","unstructured":"Maglich JM, Lobe DC, Moore JT (2009) The nuclear receptor CAR (NR1I3) regulates serum triglyceride levels under conditions of metabolic stress. J Lipid Res 50(3):439\u2013445. https:\/\/doi.org\/10.1194\/jlr.M800226-JLR200","journal-title":"J Lipid Res"},{"issue":"3","key":"4099_CR35","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1677\/joe-07-0126","volume":"194","author":"N Masumoto","year":"2007","unstructured":"Masumoto N, Tateno C, Tachibana A et al (2007) GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver. J Endocrinol 194(3):529\u2013537. https:\/\/doi.org\/10.1677\/joe-07-0126","journal-title":"J Endocrinol"},{"issue":"1","key":"4099_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jat.2949","volume":"34","author":"ME Meek","year":"2014","unstructured":"Meek ME, Boobis A, Cote I et al (2014a) New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis. J Appl Toxicol 34(1):1\u201318. https:\/\/doi.org\/10.1002\/jat.2949","journal-title":"J Appl Toxicol"},{"issue":"6","key":"4099_CR37","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jat.2984","volume":"34","author":"ME Meek","year":"2014","unstructured":"Meek ME, Palermo CM, Bachman AN, North CM, Jeffrey Lewis R (2014b) Mode of action human relevance (species concordance) framework: evolution of the Bradford Hill considerations and comparative analysis of weight of evidence. J Appl Toxicol 34(6):595\u2013606. https:\/\/doi.org\/10.1002\/jat.2984","journal-title":"J Appl Toxicol"},{"issue":"6","key":"4099_CR38","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/jnci\/66.6.1037","volume":"66","author":"SH Moolgavkar","year":"1981","unstructured":"Moolgavkar SH, Knudson AG (1981) Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst 66(6):1037\u20131052. https:\/\/doi.org\/10.1093\/jnci\/66.6.1037","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"4099_CR39","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41580-018-0086-y","volume":"20","author":"IM Moya","year":"2019","unstructured":"Moya IM, Halder G (2019) Hippo-YAP\/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol 20(4):211\u2013226. https:\/\/doi.org\/10.1038\/s41580-018-0086-y","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"4099_CR40","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2131\/jts.42.773","volume":"42","author":"Y Okuda","year":"2017","unstructured":"Okuda Y, Kushida M, Kikumoto H et al (2017a) Evaluation of the human relevance of the constitutive androstane receptor-mediated mode of action for rat hepatocellular tumor formation by the synthetic pyrethroid momfluorothrin. J Toxicol Sci 42(6):773\u2013788. https:\/\/doi.org\/10.2131\/jts.42.773","journal-title":"J Toxicol Sci"},{"issue":"2","key":"4099_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/toxsci\/kfx102","volume":"158","author":"Y Okuda","year":"2017","unstructured":"Okuda Y, Kushida M, Sumida K et al (2017b) Mode of action analysis for rat hepatocellular tumors produced by the synthetic pyrethroid momfluorothrin: evidence for activation of the constitutive androstane receptor (CAR) and mitogenicity in rat hepatocytes. Toxicol Sci 158(2):412\u2013430. https:\/\/doi.org\/10.1093\/toxsci\/kfx102","journal-title":"Toxicol Sci"},{"issue":"2","key":"4099_CR42","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/toxsci\/kfx281","volume":"162","author":"RC Peffer","year":"2018","unstructured":"Peffer RC, Cowie DE, Currie RA, Minnema DJ (2018) Sedaxane-use of nuclear receptor transactivation assays, toxicogenomics, and toxicokinetics as part of a mode of action framework for rodent liver tumors. Toxicol Sci 162(2):582\u2013598. https:\/\/doi.org\/10.1093\/toxsci\/kfx281","journal-title":"Toxicol Sci"},{"issue":"4","key":"4099_CR43","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.lfs.2006.09.015","volume":"80","author":"VO Pustylnyak","year":"2007","unstructured":"Pustylnyak VO, Lebedev AN, Gulyaeva LF, Lyakhovich VV, Slynko NM (2007) Comparative study of CYP2B induction in the liver of rats and mice by different compounds. Life Sci 80(4):324\u2013328. https:\/\/doi.org\/10.1016\/j.lfs.2006.09.015","journal-title":"Life Sci"},{"issue":"8","key":"4099_CR44","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1177\/0192623313482055","volume":"41","author":"Y Sakamoto","year":"2013","unstructured":"Sakamoto Y, Inoue K, Takahashi M et al (2013) Different pathways of constitutive androstane receptor mediated liver hypertrophy and hepatocarcinogenesis in mice treated with piperonyl butoxide or decabromodiphenyl ether. Toxicol Pathol 41(8):1078\u20131092. https:\/\/doi.org\/10.1177\/0192623313482055","journal-title":"Toxicol Pathol"},{"issue":"7","key":"4099_CR45","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1124\/dmd.109.031872","volume":"38","author":"N Scheer","year":"2010","unstructured":"Scheer N, Ross J, Kapelyukh Y, Rode A, Wolf CR (2010) In vivo responses of the human and murine pregnane X receptor to dexamethasone in mice. Drug Metab Dispos 38(7):1046\u20131053. https:\/\/doi.org\/10.1124\/dmd.109.031872","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"4099_CR46","first-page":"839","volume":"43","author":"R Schulte-Hermann","year":"1983","unstructured":"Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J (1983) Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Can Res 43(2):839\u2013844","journal-title":"Can Res"},{"issue":"1","key":"4099_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/toxsci\/kfad129","volume":"198","author":"R Shizu","year":"2024","unstructured":"Shizu R, Makida N, Sobe K et al (2024) Interaction with YAP underlies the species differences between humans and rodents in CAR-dependent hepatocyte proliferation. Toxicol Sci 198(1):101\u2013112. https:\/\/doi.org\/10.1093\/toxsci\/kfad129","journal-title":"Toxicol Sci"},{"issue":"4","key":"4099_CR48","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1177\/0192623311406935","volume":"39","author":"FD Sistare","year":"2011","unstructured":"Sistare FD, Morton D, Alden C et al (2011) An analysis of pharmaceutical experience with decades of rat carcinogenicity testing: support for a proposal to modify current regulatory guidelines. Toxicol Pathol 39(4):716\u2013744. https:\/\/doi.org\/10.1177\/0192623311406935","journal-title":"Toxicol Pathol"},{"issue":"2","key":"4099_CR49","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1006\/rtph.2001.1493","volume":"34","author":"C Sonich-Mullin","year":"2001","unstructured":"Sonich-Mullin C, Fielder R, Wiltse J et al (2001) IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul Toxicol Pharmacol 34(2):146\u2013152. https:\/\/doi.org\/10.1006\/rtph.2001.1493","journal-title":"Regul Toxicol Pharmacol"},{"issue":"10","key":"4099_CR50","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1007\/s00204-022-03338-7","volume":"96","author":"H Sprenger","year":"2022","unstructured":"Sprenger H, Rasinger JD, Hammer H et al (2022) Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver. Arch Toxicol 96(10):2739\u20132754. https:\/\/doi.org\/10.1007\/s00204-022-03338-7","journal-title":"Arch Toxicol"},{"issue":"17","key":"4099_CR51","doi-asserted-by":"publisher","first-page":"13246","DOI":"10.3390\/ijms241713246","volume":"24","author":"C Strupp","year":"2023","unstructured":"Strupp C, Corvaro M, Cohen SM et al (2023) Increased cell proliferation as a key event in chemical carcinogenesis: application in an integrated approach for the testing and assessment of non-genotoxic carcinogenesis. Int J Mol Sci 24(17):13246. https:\/\/doi.org\/10.3390\/ijms241713246","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4099_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.toxlet.2013.05.011","volume":"221","author":"K Tamura","year":"2013","unstructured":"Tamura K, Inoue K, Takahashi M et al (2013) Dose-response involvement of constitutive androstane receptor in mouse liver hypertrophy induced by triazole fungicides. Toxicol Lett 221(1):47\u201356. https:\/\/doi.org\/10.1016\/j.toxlet.2013.05.011","journal-title":"Toxicol Lett"},{"key":"4099_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s42826-019-0032-y","author":"C Tateno","year":"2020","unstructured":"Tateno C, Kojima Y (2020) Characterization and applications of chimeric mice with humanized livers for preclinical drug development. Lab Anim Res. https:\/\/doi.org\/10.1186\/s42826-019-0032-y","journal-title":"Lab Anim Res"},{"issue":"3","key":"4099_CR54","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0002-9440(10)63352-4","volume":"165","author":"C Tateno","year":"2004","unstructured":"Tateno C, Yoshizane Y, Saito N et al (2004) Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 165(3):901\u2013912. https:\/\/doi.org\/10.1016\/S0002-9440(10)63352-4","journal-title":"Am J Pathol"},{"issue":"11","key":"4099_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142145","volume":"10","author":"C Tateno","year":"2015","unstructured":"Tateno C, Kawase Y, Tobita Y et al (2015) Generation of novel chimeric mice with humanized livers by using hemizygous cDNA-uPA\/SCID mice. PLoS ONE 10(11):e0142145. https:\/\/doi.org\/10.1371\/journal.pone.0142145","journal-title":"PLoS ONE"},{"key":"4099_CR56","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.mrgentox.2019.01.003","volume":"839","author":"C Tateno","year":"2019","unstructured":"Tateno C, Fukumuro M, Masumori S et al (2019) Chimeric mice with human hepatocytes: A new system for genotoxicity studies. Mutat Res\/genet Toxicol Environ Mutagenesis 839:9\u201312. https:\/\/doi.org\/10.1016\/j.mrgentox.2019.01.003","journal-title":"Mutat Res\/genet Toxicol Environ Mutagenesis"},{"issue":"3","key":"4099_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1293\/tox.25.189","volume":"25","author":"B Thoolen","year":"2012","unstructured":"Thoolen B, Ten Kate FJ, van Diest PJ, Malarkey DE, Elmore SA, Maronpot RR (2012) Comparative histomorphological review of rat and human hepatocellular proliferative lesions. J Toxicol Pathol 25(3):189\u2013199. https:\/\/doi.org\/10.1293\/tox.25.189","journal-title":"J Toxicol Pathol"},{"issue":"10\u201311","key":"4099_CR58","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1080\/00498250600861827","volume":"36","author":"ES Tien","year":"2006","unstructured":"Tien ES, Negishi M (2006) Nuclear receptors CAR and PXR in the regulation of hepatic metabolism. Xenobiotica 36(10\u201311):1152\u20131163. https:\/\/doi.org\/10.1080\/00498250600861827","journal-title":"Xenobiotica"},{"issue":"1","key":"4099_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.61.1.1","volume":"61","author":"A Ueda","year":"2002","unstructured":"Ueda A, Hamadeh HK, Webb HK et al (2002) Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. Mol Pharmacol 61(1):1\u20136","journal-title":"Mol Pharmacol"},{"issue":"1\u20132","key":"4099_CR60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0163-7258(96)00067-8","volume":"71","author":"J Whysner","year":"1996","unstructured":"Whysner J, Ross PM, Williams GM (1996) Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. Pharmacol Ther 71(1\u20132):153\u2013191. https:\/\/doi.org\/10.1016\/0163-7258(96)00067-8","journal-title":"Pharmacol Ther"},{"issue":"6","key":"4099_CR61","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1177\/0192623315576005","volume":"43","author":"CE Wood","year":"2015","unstructured":"Wood CE, Hukkanen RR, Sura R et al (2015) Scientific and regulatory policy committee (SRPC) review: Interpretation and use of cell proliferation data in cancer risk assessment. Toxicol Pathol 43(6):760\u2013775. https:\/\/doi.org\/10.1177\/0192623315576005","journal-title":"Toxicol Pathol"},{"issue":"4","key":"4099_CR62","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1039\/c7tx00288b","volume":"7","author":"T Yamada","year":"2018","unstructured":"Yamada T (2018) Case examples of an evaluation of the human relevance of the pyrethroids\/pyrethrins-induced liver tumours in rodents based on the mode of action. Toxicol Res (Camb) 7(4):681\u2013696. https:\/\/doi.org\/10.1039\/c7tx00288b","journal-title":"Toxicol Res (Camb)"},{"issue":"4","key":"4099_CR63","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1293\/tox.2021-0027","volume":"34","author":"T Yamada","year":"2021","unstructured":"Yamada T (2021) Application of humanized mice to toxicology studies: evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). J Toxicol Pathol 34(4):283\u2013297. https:\/\/doi.org\/10.1293\/tox.2021-0027","journal-title":"J Toxicol Pathol"},{"issue":"1","key":"4099_CR64","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/toxsci\/kfu173","volume":"142","author":"T Yamada","year":"2014","unstructured":"Yamada T, Okuda Y, Kushida M et al (2014) Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver. Toxicol Sci 142(1):137\u2013157. https:\/\/doi.org\/10.1093\/toxsci\/kfu173","journal-title":"Toxicol Sci"},{"issue":"4","key":"4099_CR65","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1039\/c4tx00217b","volume":"4","author":"T Yamada","year":"2015","unstructured":"Yamada T, Kikumoto H, Lake BG, Kawamura S (2015) Lack of effect of metofluthrin and sodium phenobarbital on replicative DNA synthesis and Ki-67 mRNA expression in cultured human hepatocytes. Toxicol Res 4(4):901\u2013913. https:\/\/doi.org\/10.1039\/c4tx00217b","journal-title":"Toxicol Res"},{"issue":"2","key":"4099_CR66","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/toxsci\/kfaa125","volume":"177","author":"T Yamada","year":"2020","unstructured":"Yamada T, Ohara A, Ozawa N et al (2020) Comparison of the hepatic effects of phenobarbital in chimeric mice containing either rat or human hepatocytes with humanized constitutive androstane receptor and pregnane X receptor mice. Toxicol Sci 177(2):362\u2013376. https:\/\/doi.org\/10.1093\/toxsci\/kfaa125","journal-title":"Toxicol Sci"},{"issue":"5","key":"4099_CR67","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/10408444.2021.1939654","volume":"51","author":"T Yamada","year":"2021","unstructured":"Yamada T, Cohen SM, Lake BG (2021) Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR). Crit Rev Toxicol 51(5):373\u2013394. https:\/\/doi.org\/10.1080\/10408444.2021.1939654","journal-title":"Crit Rev Toxicol"},{"issue":"20","key":"4099_CR68","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.1158\/0008-5472.CAN-04-1459","volume":"64","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto Y, Moore R, Goldsworthy TL, Negishi M, Maronpot RR (2004) The orphan nuclear receptor constitutive active\/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. Cancer Res 64(20):7197\u20137200. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1459","journal-title":"Cancer Res"},{"issue":"8","key":"4099_CR69","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1248\/bpb.b19-00267","volume":"42","author":"K Yoshinari","year":"2019","unstructured":"Yoshinari K (2019) Role of nuclear receptors PXR and CAR in xenobiotic-induced hepatocyte proliferation and chemical carcinogenesis. Biol Pharm Bull 42(8):1243\u20131252. https:\/\/doi.org\/10.1248\/bpb.b19-00267","journal-title":"Biol Pharm Bull"},{"issue":"7","key":"4099_CR70","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1124\/dmd.121.000481","volume":"50","author":"K Yoshinari","year":"2022","unstructured":"Yoshinari K, Shizu R (2022) Distinct roles of the sister nuclear receptors PXR and CAR in liver cancer development. Drug Metab Dispos 50(7):1019\u20131026. https:\/\/doi.org\/10.1124\/dmd.121.000481","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"4099_CR71","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0006-2952(97)00476-0","volume":"55","author":"H Zaher","year":"1998","unstructured":"Zaher H, Yang TJ, Gelboin HV, Fernandez-Salguero P, Gonzalez FJ (1998) Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-null mouse. Biochem Pharmacol 55(2):235\u2013238. https:\/\/doi.org\/10.1016\/s0006-2952(97)00476-0","journal-title":"Biochem Pharmacol"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04099-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-025-04099-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-025-04099-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T12:43:08Z","timestamp":1756903388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-025-04099-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,9]]},"references-count":71,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["4099"],"URL":"https:\/\/doi.org\/10.1007\/s00204-025-04099-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,9]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Samuel M. Cohen consults for Sumitomo Chemical Company, Ltd. The other authors are employed by Sumitomo Chemical Company, Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}